Genetic mutations in human DNA can prevent proteins that perform important functions in the body from being formed correctly. This can lead to serious disorders that cause disease or even disability.
The advent of ultrahigh-throughput next-generation sequencing (NGS) offers an improved approach to endocrine molecular diagnostics. There are three basic paradigms in which this technology is usually ...
Additional AI-derived literature references for thousands of additional genes in the clinical genome to supplement QIAGEN-curated content. The unique combination of human-certified and AI-derived ...
Understanding Bioinformatics Workflows for NGS Analysis: Case Study with Whole-exome Sequencing Data
NGS enables the in-depth analysis of the genome and the identification and investigation of disease-associated variants–especially when workflows include target enrichment, which focuses on specific ...
Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, today announced enhancements to its Whole Genome Sequencing (WGS) test with the ...
Scientists at the Baylor College of Medicine and collaborating institutions used complementary approaches that integrate exome sequencing and evolutionary action machine learning to identify protein ...
GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today ...
Global Burden of Thyroid Cancer in Adults Age 15-49 Years and Its Predictions: Findings From Global Burden of Disease Study 2021 We conducted whole-exome sequencing on 100 (N = 100) tumor-normal ...
Agilent Technologies introduced SureSelect Human All-Exon V5 and V5 + UTRs for next-generation sequencing. The new all-exon solutions incorporate the latest advances from Agilent Genomics, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results